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A B S T R A C T
Brain energetic requirements are elevated due to the high cost of impulse transmission and informa-
tion storage, and are met mainly by glucose oxidation. The energy needs are closely matched by metabolic
regulation, which requires the close cooperation of neurons and astrocytes and involves highly regu-
lated ﬂuxes of metabolites between cells. The metabolism in each type of cell is determined in part by
its proteomic proﬁle, which has been regarded as complementary. This review will consider the cellular
distribution of the mitochondrial aspartate–glutamate carrier, aralar/AGC1/SLC25A12, and its role in the
synergic metabolism between neurons and astrocytes.
© 2015 Elsevier Ltd. All rights reserved.
Neuroenergetic processes are essential for brain function. Brain’s
energy demand accounts for about 25% of total body glucose usage,
even if brain represents approximately 2% of body weight. This is
mainly caused by the high biosynthetic needs for synaptic plastic-
ity and the stringent control of ionic homeostasis across cell
membranes, which is essential to keep the necessary electrical prop-
erties for signal transmission, most of which is mediated by the
neurotransmitter glutamate (Belanger et al., 2011). Neurons are the
cells in charge of processing the information, encoded as electri-
cal impulses, and therefore are considered the highest energy
demanding cells in the brain. In fact, astrocytes were considered for
a long time only as silent bystanders whose role was to support and
nurture neurons (Navarrete and Araque, 2014). This view of astro-
cytes as second tier players has been challenged and reconsidered
over the past decades with the recognition that astrocytes receive
and integrate signals from neurons. Astrocytes thus actively respond
to synaptic activity supporting the increase in metabolic demand
associated with information integration and plasticity and releas-
ing gliotransmitters (Perea et al., 2009), although the latter has
recently been challenged (Fujita et al., 2014). In any event, neurons
and astrocytes need to act coordinately for the correct integration
and storage of information, a cooperation based in transcellular ﬂuxes
of metabolites. Two aspects of the metabolic relationship have re-
ceived great attention, the glucose utilization during brain
stimulation and the glutamate/glutamine cycle.
Glucose is the main energy substrate for brain. Brain energy me-
tabolism is highly oxidative, with an oxygen glucose index near to
the theoretical maxima of six oxygen molecules per glucose mol-
ecule completely oxidized to CO2+H2O (Dienel, 2012a). However,
during brain activation there is a mismatch between increases in
cerebral metabolic rate of oxygen and glucose consumption, which
returns a lowered oxygen glucose index by approximately 10%, to-
gether with net eﬄux of lactate from the brain (Dienel, 2012a,
2012b). Which cells are responsible for the increased lactate pro-
duction? In vivo functional imaging of brain activity, although of
invaluable usefulness formonitoring task evoked activation of regions
and overall metabolism changes, lacks enough spatial resolution to
answer the question. Therefore, the actual locus for lactate pro-
duction, i.e. neuron or astrocyte, is a matter of debate, as lactate
production has been reported to take place in both types of cells
(Caesar et al., 2008; Mangia et al., 2009; Pellerin and Magistretti,
2013).
Glutamate is the main excitatory neurotransmitter, but has also
other functions in the brain. Glutamate can also be used as energy
fuel (McKenna, 2013) and it is the precursor of γ-aminobutyric acid
(GABA), glutathione and other amino acids. Thus the metabolism
of glutamate (and its derivates) has received much attention. It is
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widely accepted that, after synaptic release, astrocytes eﬃciently
take up glutamate reducing its concentration in the cleft. In the as-
trocytes, glutamate may be converted into glutamine, which has no
excitatory effect and therefore can be returned to neurons. There,
glutamine will regenerate glutamate for neurotransmitter vesicle
loading. This coordinated process between neurons and astro-
cytes is known as the glutamate–glutamine cycle and is considered
central to glutamate homeostasis (Berl and Clarke, 1983; Daikhin
and Yudkoff, 2000), although it is a simpliﬁed view of the process.
In fact, the fate of glutamate taken up by astrocytes differs regard-
ing its concentration as shown in astrocytic cultures where low
glutamate concentration enhanced glutamine synthesis whereas
larger glutamate concentration favored oxidative use of the amino
acid in astrocytes (McKenna et al., 1996). In the neurons there may
be also some carbon loss from the cycle due to oxidative metabo-
lism of glutamine (Hertz, 2013; McKenna, 2013; Rothman et al.,
2011). Because glutamate does not cross the blood–brain barrier
(Hawkins et al., 1995), the loss of glutamate neurotransmitter has
to be compensated by de novo synthesis of glutamine in astro-
cytes, which express both the anaplerotic enzyme pyruvate
carboxylase and the glutamine synthetase (Norenberg and
Martinez-Hernandez, 1979; Shank et al., 1985).
Fluxes between neurons and glia are central to their metabolic
interaction and are sustained by diverse proﬁle expression of trans-
porters and enzymes involved. The varied expression of proteins
or isoforms with different kinetic properties is relevant to deter-
mine the directionality of a cycle, the preferred energy fuel or the
most likely pathway to take place within or between them. For
example, the high aﬃnity monocarboxylate carrier MCT2 is asso-
ciated with nerve endings as opposed to low aﬃnity isoformsMCT1
and MCT4 expression in astrocytes. This differential cellular distri-
bution has been interpreted to reﬂect a neuronal preference for
lactate as oxidative substrate when compared with astrocytes
(Pellerin and Magistretti, 2013). However, it should be noted that
both astrocytes and neurons can oxidize lactate for energy (McKenna
et al., 1993). On the other hand, the differential expression between
glutamine synthetase which is expressed only in astrocytes
(Norenberg andMartinez-Hernandez, 1979) and glutaminase, which
is expressed in both cell types but is more active in neurons (Cardona
et al., 2014; Hogstad et al., 1988), together with distinct gluta-
mate and glutamine uptake systems in astrocytes and neurons
respectively, is determinant of the glutamate/glutamine cycle di-
rection (Berl and Clarke, 1983; Daikhin and Yudkoff, 2000; Rothman
et al., 2012).
Aralar, as member of the malate–aspartate shuttle, plays an im-
portant role in oxidative glucose metabolism, glutamine synthesis
and glutamate oxidation. It has been reported to be expressed only
in neurons, at least during postnatal development (Pardo et al., 2013,
and references there-in) but this view is challenged by aralar mRNA
being found in acutely isolated astrocytes (Lovatt et al., 2007). In
any event, lower expression of aralar in glial cells would make them
dependent on transcellular ﬂuxes of neuronal born metabolites, like
aspartate and N-acetyl aspartate. Therefore, the presence of aralar
in adult glia is still a matter of debate and should be studied because
of its relevance for understanding the synergies between neurons
and glia in norm and pathology.
1. Cell localization of aralar, the brain speciﬁc
aspartate–glutamate carrier
Aralar/AGC1/SLC25A12 is the brain isoform of the mitochon-
drial aspartate–glutamate carrier (AGC). Aralar belongs to the
superfamily of the mitochondrial carriers and participates in the
malate–aspartate shuttle (MAS, Figure 1). Aralar and the AGC liver
isoform citrin have Ca2+ bindingmotives in its amino terminal domain
facing the intermembrane space that confer Ca2+ sensitivity (del Arco
and Satrustegui, 1998; Satrustegui et al., 2007). Thus, transport and
MAS activities are activated by extramitochondrial calcium in-
creases below those promoting Ca2+ uptake through the calcium
uniporter (Contreras et al., 2007; Pardo et al., 2006). As an essen-
tial member of MAS, aralar will in part determine the extent of
oxidativemetabolism in the cellular type (neuron or astrocyte) where
it is expressed (see discussion later). Aspartate eﬄux from its pro-
duction site in mitochondria requires aralar (Pardo et al., 2013), and
therefore aralar expression will determine if a cell can use endog-
enous aspartate or relies in transcellular ﬂux of exogenous aspartate
for its cytosolic use. This section will explore the current evi-
dences for aralar cellular localization within the brain.
In culture, both neurons and astrocytes express aralar, as deter-
mined by western blot. Expression was lower in astrocytes than in
neurons, where it is associated with an increase of aralar protein
levels during in vitro neuronal development which was also ob-
served in vivo (Ramos et al., 2003). Consistently, enriched cortical
neurons from E15-16 embryos grown in Neurobasal medium with
glucose as main oxidative substrate (85–90% neuronal purity with
some astrocyte contamination, Pardo et al., 2006) from a mouse
model deﬁcient in aralar exhibited profound metabolic distur-
bances, among which are the increase in lactate production and the
decreased aspartate levels that can be traced back directly to the
absence of aralar activity (Pardo et al., 2011). On the other hand,
astrocytes in culture express aralar and the liver isoform of the AGC,
citrin, which was not found in neuronal cultures (Ramos et al., 2003).
Citrin is practically undetectable at the protein and mRNA levels in
the brain, where it is restricted to a few neuronal clusters (Contreras
et al., 2010; Ramos et al., 2003). Astrocytes cultured from aralar KO
mice did not have the metabolic alterations observed in neuronal
cultures, as expected if aralar had an actual role in glucose oxida-
tive metabolism of cultured astrocytes, i.e. no changes in aspartate
levels and neither alteration in lactate/pyruvate utilization ratios
were observed in aralar deﬁcient astrocytes (Pardo et al., 2011). Thus,
expression of both AGCs, aralar and citrin, in cultured astrocytes,
which is readily observed by western blotting (Ramos et al., 2003),
should be regarded with caution as may be an effect of the partial
de-differentiation suffered by cells in culture (Lindsay et al., 2014;
Lodin et al., 1979) or even reﬂect the presence of undifferentiated
progenitors that express aralar (Ramos et al., 2003). In general, cul-
tured astroglia should be regarded as an astrocyte-like cell type and
may not represent in all aspects their in vivo counterparts.
In the brain, in situ mRNA hybridization pattern pointed to
neurons as the cells expressing aralar (Ramos et al., 2003). However,
it could be argued that the in situ hybridization has poor spatial res-
olution. A compromise between tissue slices and cultured cells is
to acutely isolate brain cells and separate them afterwards to obtain
pure populations. This is possible nowadays with promoter di-
rected expression of ﬂuorescent proteins toward a speciﬁc cell types
in vivo, followed by ﬂuorescence activated cell sorting (FACS) of brain
isolated cells. Using this approach, Lovatt et al. (2007) isolated cells
from a mouse model expressing GFP or YFP under the control of
GFAP and Thy-1 promoter respectively, and analyzed the RNA proﬁle
of the sorted populations. No differences were found for aralar at
the mRNA level between acutely isolated neurons and glial cells,
which were shown to have an active glucose oxidative metabo-
lism, as would be expected if aralar is present to allowMAS activity
(Lovatt et al., 2007). However, Cahoy et al. (2008), employing a dif-
ferent mouse model with EGFP under the S100B promoter to sort
neurons (EGFP−) and astrocytes (EGFP+), found aralar preferen-
tially expressed in neurons. Another work used translating ribosome
aﬃnity puriﬁcation (TRAP) methodology to study the RNA proﬁle
of different brain cell populations and also found aralar mRNA in
astrocytes, although in this article the highest expression was found
in neuronal populations (Doyle et al., 2008). In the retina, microarray
data revealed 100-fold lower aralar expression in Müller cell as
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compared with photoreceptors (Roesch et al., 2008). Thus, in most
of the studies aralar mRNA was found preferentially expressed in
embryonic rat neurons or adult rat slices (Ramos et al., 2003),
neurons from developing mice (Cahoy et al., 2008) or adult mice
(Doyle et al., 2008). However, the preferential presence of aralar
protein in neurons was also conﬁrmed (Ramos et al., 2003) with
antibodies raised against recombinant aralar (del Arco and
Satrustegui, 1998).
Li et al. (2012) used a commercial monoclonal antibody that rec-
ognized no protein in liver extract, and reported similar aralar levels
by western blot in acute isolated neurons and astrocytes from the
samemouse model as Lovatt et al. (2007). Nonetheless, the absence
of aralar from glia is in agreement with several results obtained by
biochemical and inmunolabeling classical procedures. Previous work
of immunohistochemical proﬁling by confocal microscopy found
aralar in brain with a clear if not exclusive preference for neuro-
nal populations (Berkich et al., 2007; Ramos et al., 2003). This
distribution is re-enforced by biochemical data that support the idea
of lower oxidative glucose metabolism in astrocytes compared with
neurons (Belanger et al., 2011). A mitochondrial preparation without
synaptosomes, and thus enriched in mitochondria from astrocytic
origin, showed the expected enrichment in speciﬁc glial enzymes
(pyruvate carboxylase, glutamine synthetase, mitochondrial
branched-chain amino acid transaminase), but a signiﬁcant de-
crease in aralar protein levels and aspartate production when
compared with bulk mitochondria (Berkich et al., 2007).
Aminooxyacetic acid, a general inhibitor of transminases and thus
of MAS, severely affects lactate oxidation and tends to decrease
glucose oxidation in synaptosomes, whereas in astrocytes the effect
was completely the opposite supporting the conclusion of little
shuttle activity (and aralar expression) in astrocytes (McKenna et al.,
1993). In the retina, aralar has been also shown to be enriched in
the photoreceptor cells and excluded from Müller cells, the resi-
dent glial cell type, by different speciﬁc antibodies (Lindsay et al.,
2014; Xu et al., 2007) and by proteomic analysis of retina layers
(Reidel et al., 2011). Müller cells exhibit elevated rate of aerobic gly-
colysis, with as little as 1% of glucose being transformed to CO2+H2O
(Winkler et al., 2000). This fact is consistent with lack of a shuttle
mechanism to regenerate redox power in the cytosol of Müller cells.
Finally, Pardo et al. (2011) showed at the electron microscopy
level of resolution that aralar is present in neurons and not glia. Spe-
ciﬁcally, the analysis of electron microscopy images of brain using
a highly speciﬁc aralar antibody showed that the vastmajority (≈94%)
of labeled aralar were present in neurons, where they associated
preferentially with mitochondria (Pardo et al., 2011). The residual
labeling (≈7%) has been claimed as a demonstration of aralar pres-
ence in astrocytes (Peng et al., 2013). However, the fact that the label
was distributed stochastically between mitochondria and cytosol,
and that it was similar to the noise label level obtained in parallel
experiments with aralar deﬁcient tissues, strongly backs up the
notion of aralar absence in astrocytes (Pardo et al., 2011).
Why are these differences found? Data obtained at the RNA level
should always be conﬁrmed at the protein level, and when possi-
ble, with a functional assay, because of the lack of correlation
between the levels of mRNA and protein (Peng et al., 2013). Another
divergence point may be the antibody selection, which varies within
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Fig. 1. Neuron born aspartate acts as nitrogen donor for de novo synthesis of glutamate while acting providing OAA for NADH oxidation in astrocytes. Neuronal mitochon-
dria are provided with aralar/AGC1/Slc25a12 and the oxoglutarate carrier/OGC/Slc25a11 and carry out the malate–aspartate shuttle (MAS) to transfer NADH reducing equivalents
to the mitochondrial matrix, regenerating the oxidized cofactor used in glycolysis for continuous pyruvate supply to mitochondria. In the cycle, glutamate and malate enter
the mitochondrial matrix in exchange with aspartate (through AGC) and αKetoglutarate (through OGC) respectively, while transferring the redox equivalents. Because glu-
tamate is co-transported with a proton by AGC, the cycle is unidirectional and aspartate is synthesized within the matrix in the mitochondrial aspartate aminotransferase
(mAST) reaction. For de novo synthesis of glutamine, aspartate eﬄuxes through AGC and is transferred to astrocytes, where it donates the amino group to a newly synthe-
sized αketoglutarate molecule in the cytosolic aminotransferase reaction (cAST). The new glutamate molecule by condensation with an ammonium group (from blood supply
or from the neuron via the ammonium shuttles, see text) by the glutamine synthetase (GS) activity is converted to glutamine, that may be transported back to the neurons
for incorporation to vesicles as glutamate after glutaminase activity (not depicted). The OAA formed in astrocytes from aspartate can also be used in the malate dehydro-
genase (cMDH) reaction to regenerate NAD+ for glycolysis in the astrocytes, as an alternative to MAS in these cells. Then malate may return to neurons to regenerate aspartate
(not shown). Alternatively, malate may enter the mitochondria in exchange with OGC (present also in glia), and incorporate to TCA to produce NADH and OAA (mMDH).
The other redox equivalent for glucose oxidation may arise from alternative redox shuttles (Pardo and Contreras, 2012) or from oxidation of glutamate to lactate. For sim-
plicity, the glutamine export to neurons and further metabolism to glutamate are not shown. AcCoA, Acetyl Coenzyme A; AGC, aspartate–glutamate carrier; Asp, aspartate;
AST, cytosolic aspartate aminotransferase; Gln, glutamine; Glu, glutamate; GS, glutamine synthetase; α-ketoglutarate, α-ketoglutarate; Mal, malate; MDH, malate dehy-
drogenase; MPC, mitochondrial pyruvate carrier, OAA, oxaloacetic acid; OGC, α-ketoglutarate–malate carrier; PDH pyruvate dehydrogenase; PC, pyruvate carboxlyase; Pyr,
pyruvate, TCA, tricarboxylic acid cycle.
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the studies presented and may have different speciﬁcities or aﬃni-
ties. Furthermore, as antibodies may bind to different unspeciﬁc
proteins in different tissues, care should be taken and appropriate
controls carried out in parallel to rule out false positives, with use
of knock out samples of the tissue of interest being the best choice
(Bordeaux et al., 2010; Zhang et al., 2003). It also should be noted
that different animal models were used among the literature, and
therefore the genetic variation between strains should be taken into
account (Keane et al., 2011). For example, different AGC levels
between mouse strains have been reported by western blot of heart
extracts (Contreras et al., 2007). Finally, the age of the animal at the
time of investigation should be considered. Metabolism changes from
neonatal to adulthood, with upregulation or downregulation of key
participants of metabolic pathways taking place. For example, aralar
enrichment in neurons during the neonatal period would favor the
building up of glutamate/glutamine pools that takes place (Morken
et al., 2014) providing the carbon for de novo synthesis while se-
lectively using glucose in anaplerotic pathways in the astrocytes (will
be discussed later). In summary, due to the pivotal role of the aralar
in brain metabolism, its localization should be conﬁrmed beyond
doubt in future studies.
The following sections will discuss the role of aralar in brain me-
tabolism and in themetabolite ﬂuxes between neuron and astrocytes.
2. Role of aralar in glucose oxidation
Brain cells use almost exclusively glucose as energy substrate,
ketone bodies being the alternative during development and star-
vation (Belanger et al., 2011; Nehlig, 2004). After glycolysis, pyruvate
generated in the cytosol is transported to the mitochondrial matrix
where it is converted to acetyl-CoA for complete glucose oxida-
tion at the tricarboxylic acid cycle (TCA, Fig. 1). Glycolysis also
generates NADH, and the oxidized cofactor in the cytosol needs to
be regenerated to avoid glycolysis block at the glyceraldehyde–
phosphate dehydrogenase step. Mitochondria are impermeable to
both NAD+ and NADH, and thus cells have evolved mechanisms to
shuttle redox equivalents into the mitochondrial matrix. In brain,
MAS is considered the main shuttle system as there is controversy
upon the actual presence of a working glycerol-3-phospahte shuttle
in brain cells. Redox balance can also be regained with the help of
alternative (and minor) redox shuttles, and by reduction of pyru-
vate to lactate, but no redox power is transferred to mitochondria
in this situation which is less eﬃcient from an energetic point of
view (Pardo and Contreras, 2012).
The prominent role of aralar, as part of MAS, in neurons is evident
from the phenotype of the aralar deﬁcient neurons, which have de-
creased respiration levels with glucose as fuel (Llorente-Folch et al.,
2013). Furthermore, neurons lacking aralar are unable to regulate
their respiration rates in response to Ca2+ transients, which would
compromise the adequate response to energetic demands during
stimulation (Llorente-Folch et al., 2013).
Astrocytes have reduced oxidative glucose metabolism (Belanger
et al., 2011; McKenna et al., 1993), which may be considered a con-
sequence of the low levels of shuttle activity due to little if not
complete lack of aralar levels (see previous section). In cultured as-
trocytes, aerobic glycolysis was demonstrated to fuel the ATP
necessary to eﬄux Na+ after glutamate co-uptake from the synap-
tic cleft, providing a mechanism by which brain energy metabolism
is tightly coupled to synaptic activity (Magistretti et al., 1999). The
astroglial produced lactate was proposed to be exported to neurons
for oxidative use (astrocyte–neuron lactate shuttle, ANLS) and lactate
was shown to provide energy for synaptic transmission, a fact which
seemed to support the hypothesis (Pellerin and Magistretti, 2013
for review). However, this shuttle hypothesis is based mainly on in
vitro data, and has been challenged based on mathematical models
and experimental data showing that neurons are also able to produce
lactate during activity bursts, and thus may contribute also the net
lactate eﬄux during brain activation (Caesar et al., 2008; Dienel,
2012a, 2012b; DiNuzzo et al., 2010a, 2010b; Gjedde and Marrett,
2001; Lindsay et al., 2014; Mangia et al., 2009). Recently, Patel et al.
(2014) have demonstrated in vivo up-regulation of neuronal glucose
metabolism as shown by increased glucose phophorylation, a fact
that would also undermine the importance of astrocytic lactate as
fuel to neurons in response to activation conditions. On the other
hand, aerobic glycolysis in neurons which have robust MAS activ-
ity may seem paradoxical. However, MAS activity may become
impaired by high Ca2+ concentrations as those that may take place
during neuronal activity and that reach the mitochondrial matrix.
Indeed, shuttle reconstitution with isolated mitochondria showed
that intramitochondrial Ca2+ activation of αketoglutarate-
dehydrogenase reduces eﬄux through the oxoglutarate carrier
decreasing overall MAS activity, due to the competition of the two
pathways, MAS and TCA, for a shared common metabolite,
αketoglutarate (Contreras and Satrustegui, 2009). MAS inhibition
by this mechanism has been proposed to take place in cultured
neurons (Bak et al., 2012) and may divert pyruvate to lactate pro-
duction (aerobic glycolysis) thus partially explaining the mismatch
between glucose and O2 utilization upon brain activation (Dienel,
2012a), thus adding to other evidences in favor of lactate produc-
tion by neurons and undermining the hypothesis of Magistretti and
coworkers. It should be noted that MAS inhibition occurs at OGC
level, which means that the AGC may remain active and contrib-
ute to the oxidative use of glutamate in a truncated TCA cycle
(Yudkoff et al., 1994), as an alternative to impaired glucose oxida-
tion. Importantly, isolated mitochondria from aralar deﬁcient mice
have reduced respiration with glutamate/malate but not with other
respiratory fuels (Jalil et al., 2005) and therefore aralar is likely to
play a role in the in vivo oxidation of glutamate.
In summary, aralar–MAS pathway is essential for proper glucose
oxidative metabolism in neurons. The higher metabolic demand
during brain activation leads to an increase in glucose metabolism
with enhanced production of lactate whose site of production and
further fate remains a matter of debate. The recent in vivo data pre-
sented by Patel et al. (2014) of increased glucose metabolism,
together with demonstration of lactate production by neurons and
the possibility of MAS inhibition during brain activity in vivo, ques-
tion the central role of the astrocyte–neuron lactate shuttle, which
may still be important in selected scenarios.
3. Role of aralar in de novo synthesis of glutamate
In the brain the glutamate/glutamine cycle is essential for eﬃ-
cient neurotransmission and glutamate homeostasis. However, the
cycle is not stoichiometric and carbons are lost to oxidation (Hertz,
2013; McKenna, 2007). Indeed, part of the glutamate taken up by
the astrocytes may be oxidized to satisfy the energetic demand of
the uptake process and glutamine synthesis (Hertz, 2013; McKenna,
2013; Sonnewald et al., 1993) and thus become an alternative to
the energy production pathway described previously (Magistretti
et al., 1999). Glutamine can also be oxidized, probably in the neuron
where the vast majority of glutaminase activity is present (Hogstad
et al., 1988). Wherever the oxidation takes place, it drains 10–15%
of cycle carbons, which is balanced by the anaplerotic synthesis of
glutamate/glutamine in astrocytes (Hertz, 2013; Rothman et al.,
2011). Net synthesis requires the speciﬁc glial enzyme pyruvate car-
boxylase to incorporate CO2 onto pyruvate to render a newmolecule
of oxaloacetate for condensation with acetyl-CoA and net synthe-
sis of αketoglutarate, which is the direct precursor of the carbon
skeleton of glutamate and therefore glutamine.
On the other hand, glutamine formation in astrocytes, either de
novo or as part of the glutamate–glutamine cycle, requires at least
one amino group, which is considered to be of neuronal origin (Bak
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et al., 2006; Rothman et al., 2012). Because simple rates of diffu-
sion or NH4 from blood supply are unknown and may be too low
and, in any case, NH4 would diffuse equally to astrocytes and neurons
(Rothman et al., 2012), twomechanisms have been proposed to carry
NH4 from neurons to astrocytes: alanine-pyruvate and the branched-
chain amino acid shuttles (Bak et al., 2006; Daikhin and Yudkoff,
2000; Hutson et al., 2001; Waagepetersen et al., 2000). In these
shuttles, NH4 produced in the glutaminase reaction (mainly in
neurons) is ﬁxed onto αketoglutarate in the glutamate dehydroge-
nase (GDH) reaction. Then glutamate donates the ammonia group
to pyruvate or αketoacid in a transamination reaction, and the non
neuroactive amino acid alanine or isoleucine/leucine formed is then
transported toward astrocytes. The opposite reactions of transami-
nation and GDH take place in astrocytes releasing NH4 for glutamine
synthesis. The actual functionality of these shuttles is under debate
for several reasons. (1) GDH Km would favor oxidation of gluta-
mate in neurons, although it has been discussed that a local high
[NH4] generated by glutaminase activity may shift the equilibrium
toward glutamate synthesis (Waagepetersen et al., 2000). (2) Spe-
ciﬁc genetic ablation of GDH in the central nervous system has little
effect on synaptic transmission and glutamate pools (Frigerio et al.,
2012), as would be expected if the alanine-pyruvate or branched-
chain amino acid shuttles were essential for glutamine synthesis.
(3) No correlation between alanine/pyruvate shuttle activity and the
glutamate–glutamine cycle was revealed by repetitive stimulation
of cultured granule cells (Bak et al., 2005). (4) Calculated ﬂux of NH4
through the proposed shuttles is 3–5 times lower to cover the
demand of glutamine formation rates in astrocytes due to both
glutamate–glutamine cycle and de novo glutamine synthesis
(Rothman et al., 2012).
Based on the ﬁndings in amurinemodel deﬁcient for aralar, Pardo
et al. (2011) suggested neuron-born aspartate (or a derivate) as the
metabolite acting as the NH4 carrier molecule (Figure 1). Aralar KO
mouse has extremely reduced levels of aspartate, and its derivate
N-acetyl aspartate (NAA) (Jalil et al., 2005). Nuclear magnetic res-
onance studies with labeled (1-13C)-glucose showed that de novo
glutamine synthesis was impaired in the brain of the aralar KOmice,
which explained the reduced levels of glutamate and glutamine in
the brains of these knock out animals. Experiments with cultured
astrocytes provided evidence that the defect was due to de-
creased neuronal-born aspartate, as (1) aspartate was reduced in
cultured neurons from aralar KO mice, but no differences were ob-
served in endogenous aspartate levels between wt and KO cultured
astrocytes in basal conditions, pointing to the lack of an exoge-
nous factor in vivo and (2) when supplemented in the incubation
medium, aspartate increased glutamine levels to a greater extent
than amino acids involved in the aforementioned NH4 shuttles (Pardo
et al., 2011). These facts suggested that aspartate (or a related me-
tabolite) produced by neurons may be required for glutamate (and
glutamine) production in astrocytes in vivo, at least during the post-
natal frame when experiments were performed.
The proposal of Pardo et al. (2011) has met some skepticism,
mainly because so far no vesicular transporter for aspartate has been
identiﬁed, as VGLUTs are speciﬁc for glutamate (Bellocchio et al.,
2000; Fremeau et al., 2001, 2002). However, aspartate is present in
synaptic vesicles and is released in a Ca2+ dependent way (Morland
et al., 2013). Recently sialin, a sialic acid lysosomal carrier, was pro-
posed to perform the uptake (Miyaji et al., 2008) but data obtained
with the sialin KO mouse argue against this role for sialin, as as-
partate uptake took place in the sialin KO mouse synaptic vesicles
(Morland et al., 2013). Whichever the uptake system identity and
release mechanism, aspartate eﬄux from neurons has been repeat-
edly observed and uptake into astrocytes demonstrated to take place
by excitatory amino acid transporters (EAATs) with similar aﬃni-
ty to glutamate (Drejer et al., 1983; Rao and Murthy, 1993). Once
in astrocytes, aspartate donates the NH4 to glutamate in a cytosolic
transmination reaction. Labeling studies in cultured astrocytes show
that the generated oxaloacetate either is converted into lactate
through pyruvate recycling or enters the TCA for oxidation or glu-
tamine generation (Bakken et al., 1997, 1998; Lindsay et al., 2014).
On the other hand, NAA, the acetyl donor for myelin synthesis,
may act also as NH4-donor. NAA is produced in neurons in the con-
densation reaction of acetyl-CoA and aspartate (Ariyannur et al.,
2010; Niwa et al., 2007; Wiame et al., 2010). Consistent with the
decreased eﬄux of aspartate from mitochondria, NAA levels de-
crease in aralar KO, leading to hypomyelinization in mouse and
human deﬁciency (“Global Cerebral Hypomyelination”, OMIM
# 612949 (Falk et al., 2014; Jalil et al., 2005; Wibom et al., 2009)).
NAA export to oligodendrocytes for myelin synthesis could also serve
as NH4 transport, as cleavage of NAA releases aspartate that maybe
used as amino donor in the transamination of αketoglutarate to glu-
tamate. However, aspartoacylase, the enzyme that break downs NAA
releasing aspartate is present in oligodendrocytes (Mattan et al.,
2010; Moffett et al., 2013) whereas both pyruvate carboxylase and
glutamine synthetase have been reported to be absent (or low) in
oligodendrocytes (Anlauf and Derouiche, 2013; Hertz, 2013). This
enzymatic expression proﬁle argues against de novo glutamate syn-
thesis in oligodendrocites using the amoniun group transported by
neuron-born NAA. Thus, aspartate released from NAA in oligoden-
drocytes by the aspartoacylase would still need to be exported to
astrocytes in order to donate the amino group to the newly formed
αketoglutarate for eﬃcient glutamine synthesis. Furthermore, the
fact that NAA is a stable molecule with a low turnover ratio (Moffett
et al., 2013) also argues against this metabolite being able to cover
the ammonium demand for glutamine synthesis.
Although not shown in Fig. 1 (for the sake of simplicity), the pro-
posed pathway requires obviously that carbons from aspartate are
returned to neurons to avoid drainage of metabolites in that com-
partment. In that respect, the malate generated in the redox reaction
may leave the astrocytic cytosol without entering the mitochon-
dria as suggested by Pardo et al. (2013) or in the form of other TCA
intermediate afterwards (Westergaard et al., 1994), and return to
neurons for carbon replenishment. Alternatively, aspartate loss in
neurons could be formed from essential amino acids or odd-chain
fatty acids (Sonnewald, 2014) and to a lesser extent, by carboxyl-
ation of pyruvate by themitochondrial malic enzyme (Hassel, 2000).
In any event, the actual route for aspartate–carbon return to neurons
has yet to be demonstrated.
In summary, the pathway proposed by Pardo et al. (2011) pro-
vides neuronal aspartate as source of ammonium groups for de novo
synthesis of glutamate in brain astrocytes. In doing so, aspartate may
also provide the astrocytic cytosol with means to transfer NADH/
NAD+ redox potential to mitochondria. However, details on the
stoichiometry of the pathway related to other important pro-
cesses such as glutamate/glutamine oxidation, glucose oxidation rates
and carbon balance within the brain demand further work.
4. Role of aralar in retina metabolism
Visual function starts with a complex biochemical cascade known
as phototransduction in highly specialized retinal cells, the photo-
receptors. Light stimulation initiates the cascade leading to
hyperpolarization of photoreceptors and cessation of glutamate
release, which is continuous in the dark (Punzo et al., 2012). Thus,
retina metabolism is faster in the dark, and requires an excellent
control of glutamate homeostasis (Bui et al., 2009). Besides the large
ATP amounts to maintain membrane potential for neurotransmis-
sion, photoreceptors need to re-synthesize daily about 10% of their
outer segments and are thus considered the highest energy con-
suming cells of the human body (Punzo et al., 2012). Not surprisingly,
metabolic alterations are a common feature of retinitis pigmentosa
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a condition of visual loss due to photoreceptor degeneration with
genetic cause (Punzo et al., 2012).
In a recent work, Du et al. (2013) studied the ﬂux of 13C-
labeled metabolites in the retina and found that glutamate, which
is readily sequestered back into photoreceptors (Hasegawa et al.,
2006), is protected from oxidation in a NADH/NAD+ dependent
manner (Figure 2A). Flux of 13C-labeled metabolites in TCA was
shown to be reduced by 100-fold at the level of succinate. This means
that about 98% αketoglutarate is protected from oxidation, likely
leaving the cycle in exchange with cytosolic malate at the
oxoglutarate carrier (Du et al., 2013). The αketoglutarate and glu-
tamate pools are in fast equilibrium by the transaminase reaction
(Mason et al., 1995), so protecting αketoglutarate from oxidation
spares glutamate for neurotransmission or anabolism. Although a
priori, AGC1 would be irrelevant for αketoglutarate eﬄux frommi-
tochondria, its activity is mandatory to supply the cytosol with
oxalacetate for malate production and αketoglutarate exchange, if
the cytosolic NADH/NAD+ ratio is adequate. The role of aralar may
be inferred in aralar deﬁcient retinas, where in spite of the el-
evated NADH/NAD+ ratio, measured as lactate/pyruvate, the ratio
glutamate/succinate falls as no protection is possible (Du et al., 2013).
In spite of the protection mechanism, some glutamate may be
oxidized and therefore re-synthesized in Müller cells. The aspar-
tate role in glutamine de novo synthesis as amino group donor (Pardo
et al., 2011) has been recently extended in the retina to also act as
carbon source in an elegant pulse-chase study (Lindsay et al., 2014)
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(Figure 2). Glutaminase and glutamine synthetase activities are en-
riched in photoreceptors andMüller cells respectively (Roesch et al.,
2008), similar to the neuron versus glia distribution in brain. Thus,
13C5-glutamine was used to pulse-label metabolites ﬁrst in photo-
receptors and then to chase them in Müller cells. The pathway
proposed involves de-amination to form 13C5-glutamate which is me-
tabolized to 13C5-αketoglutarate and then to a low extent (see
discussion earlier) to 13C4 succinate, malate and oxalacetate in pho-
toreceptors. 13C4-aspartate arising from labeled oxalacetate in the
TCA exits neuronal mitochondria through aralar and is transferred
to Müller cells (Pardo et al., 2011). In Müller cells, 13C4 aspartate acts
as donor of NH4 for glutamate synthesis while providing oxalacetate
for NADH oxidation by malate dehydrogenase. The further fate of
aspartate labeled carbons can be traced along the TCA to 13C3-
αketoglutarate, glutamate and glutamine (Lindsay et al., 2014). Based
on the effect of aspartate uptake inhibition and exogenous aspar-
tate degradation, it was concluded that the aspartate must be
produced in photoreceptors, where most of glutaminase activity is
located, and transferred toMüller cells (Lindsay et al., 2014). It should
be noted that exogenous aspartate also recovered glutamine levels
in aralar deﬁcient retinae (Lindsay et al., 2014). As discussed pre-
viously for the brain, the pathway still needs to be reﬁned in terms
of mass balance between photoreceptor and Müller cells, especial-
ly regarding the source of carbon skeleton for aspartate
replenishment in the photoreceptor.
Retinae exhibit a high aerobic glycolysis ratio, with 80–96% of
glucose converted to lactate which is released to venous blood and
to the inter-photoreceptor matrix (Ames et al., 1992; Du et al., 2013;
Wang et al., 1997a, 1997b, 1997c). The site for lactate production
was proposed to be the Müller cells, based on in vitro studies that
kept in line with the astrocyte–neuron lactate hypothesis dis-
cussed earlier (Poitry-Yamate et al., 1995; Tsacopoulos and
Magistretti, 1996). However, recent data oppose that view, rein-
forcing the idea that the lactate ﬂux from astrocytes to neuronsmight
not be as critical as it was thought to be (see Section 2). Speciﬁ-
cally, pyruvate kinase absence from Müller cells, together with
abundant expression of the M2 isoform of pyruvate kinase in pho-
toreceptors and the extreme reduction in lactate production in
retinae with no functional photoreceptors has led to the sugges-
tion of photoreceptors as the major lactate producer cells in retina
(Lindsay et al., 2014). Photoreceptor-born aspartate would also serve
to regenerate NAD+ in Müller cell’s cytosol compensating for the little
shuttle activity in Müller cells (Lindsay et al., 2014) (Fig. 2). There-
fore, aspartate was shown to enhance the oxidative use of lactate
in Müller cells, where glycolysis is severely decreased as no pyru-
vate kinase expression is likely (Lindsay et al., 2014; Roesch et al.,
2008).
The lack of pyruvate kinase and AGC1 activities in Müller cells
potentiates the anabolic pathways as opposed to energy produc-
tion: the pentose phosphate pathway is primed over glycolysis and
trapping of oxalacetate inside mitochondria primes glutamine syn-
thesis. Although this may be an advantage for anabolic purposes,
it also makes Müller cells dependent on neurons to provide me-
tabolites that act as surrogates for pyruvate kinase and AGC activities
(Lindsay et al., 2014; Roesch et al., 2008). Aspartate promotes ox-
idation of NADH to support lactate oxidation and provides both
nitrogen and carbon for de novo glutamine synthesis.
5. Conclusions
Aralar/AGC1/Slc25a12 expression in brain is primarily and
perhaps exclusively neuronal (at least in young animals), where it
plays a pivotal role in neuroenergetics, as it is essential for eﬃ-
cient glucose and lactate oxidation, and for aspartate export to
astrocytes to fuel de novo glutamine synthesis. In the retina, besides
the aforementioned roles, aralar is involved in glutamate protection
from oxidation in photoreceptors and in the export of photorecep-
tor aspartate for eﬃcient lactate oxidation in Müller cells.
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